Protein resin is a well-established and widely used technology for mAb purification. It is accepted by
Protein resin is a well-established and widely used technology for mAb purification. It is accepted by regulatory agencies, such as the FDA and EMA, for use in commercial production of mAbs. This regulatory acceptance reduces the risk of delays or rejections during the approval process for mAbs.
In conclusion, Protein A Resin is a highly effective and versatile chromatography medium for mAb purification. Its high binding capacity, specificity, consistency, scalability, flexibility, robustness, cost-effectiveness, and regulatory acceptance make it an attractive option for commercial mAb production. As the demand for mAbs continues to grow, Protein resin will likely remain a key technology in the biopharmaceutical industry.
Read More:
